Clinical Trials for Unresectable or Advanced Clear Cell Renal Cell Carcinoma That Has Progressed After Previous Immunotherapy

Find clinical trials for unresectable or advanced clear cell renal cell carcinoma that has progressed after previous immunotherapy. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

A Prospective，Single Arm, Multicenter Clinical Study of BTLA Monoclonal Antibody JS004 (B/T Lymphocyte Attenuator Factor Monoclonal Antibody) in Combination With Toripalimab in Patients With Unresectable or Advanced Renal Cell Carcinoma Who Had Failed Previous Immunotherapy

NCT ID: NCT06730932

This clinical trial is testing a new combination treatment for patients with advanced kidney cancer that cannot be surgically removed, specifically clear cell renal cell carcinoma. The treatment in...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Shanghai, Shanghai, China, China, Shanghai, , China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions